US Stock MarketDetailed Quotes

IOVA Iovance Biotherapeutics

Watchlist

9.370
-0.220-2.29%

Close Oct 16 16:00 ET

9.370
0.0000.00%

Post 19:58 ET

2.84BMarket Cap-5610P/E (TTM)

Iovance Biotherapeutics Stock Forum

EZ_money

Sep 27 06:57

$Cardio Diagnostics (CDIO.US)$ 👀👍buy businesses not fud LFG bulls
$Tencent (TCEHY.US)$ $Iovance Biotherapeutics (IOVA.US)$

BelleWeather

Sep 23 16:26

Trading Plan on Shares

I think $United Natural Foods (UNFI.US)$
is still undervalued. Originally purchased as a longterm hold, I intend to sell instead at ~25 USD and put the capital toward other trades, likely CSPs focusing on other equities for longterm holds.
A speculative hold for the longterm, though may take profit if another opportunity beckons. This is the same approach as to $MannKind (MNKD.US)$ and $Iovance Biotherapeutics (IOVA.US)$ :
Two speculative positions that I am building (similar ...

Share Your Profit/Loss

EZ_money

Sep 4 06:54

$Psyence Biomedical (PBM.US)$👈 good news out 🤑🥳🎈🎉
$Sunshine Biopharma (SBFM.US)$ $Iovance Biotherapeutics (IOVA.US)$

BelleWeather

Sep 3 07:24

Iovance

I am continuing to hold this position, but no longer adding to it as I simply am overexposed to this space. Upon reexamination, I’m neutral to hopeful this will be a solid longterm hold. (Though also a candidate to sell should another opportunity present itself.)

Share Your Profit/Loss

EZ_money

Aug 26 10:47

$Emergent BioSolutions (EBS.US)$ 👀could it be .... possible comeback? EBS is one of three companies ready to deploy mpox vaccines. With that said, you look at institutions owning this and you have the two largest with BlackRock and Vanguard..... plus Charles Schwab is no tiny outfit. $Iovance Biotherapeutics (IOVA.US)$ $Redhill Biopharma (RDHL.US)$

Trytosaveabit

Aug 21 14:02

Hey thanks Martin! Hehehe

$Iovance Biotherapeutics (IOVA.US)$ Martin Shkreli Post On X, "$IOVA Pretty Attractive Long Idea"

EZ_money

Aug 21 08:25

$GeoVax Labs (GOVX.US)$ 👀 🥳 Company to Provide a Detailed Overview of Mpox Including Commentary on the Rapid Spread and Methods for Control, Treatment, and Prevention
ATLANTA, GA, Aug. 21, 2024 (GLOBE NEWSWIRE) -- GeoVax Lab, Inc. (Nasdaq: GOVX) ("GeoVax Labs" or the "Company"), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced that David Dodd, CEO of GeoVax Labs, will present at Tribe Public's Webinar Presentation and Q&A Ev...